Marion Dorsch, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 500 shares at $64.44 ($32K) on 2017-11-21, disclosed to the SEC on 2017-11-24.
Scheduled sale ($32k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2020-10-08 | $455K | — | Filing → |
| BPMC | SELL | 2020-09-25 | $409K | — | Filing → |
| BPMC | SELL | 2020-06-23 | $363K | — | Filing → |